Lastly, as this study was performed before JCS proposed the new HF guideline in 2021 [4] and AHA/ACC/HFSA in 2022 [3], we did not consider the effects of SGLT2 inhibitors and ARNI as concomitant medications in this study. This evidence concerns the gene SLC5A2 and hydrops fetalis.